- Report
- April 2024
- 1800 Pages
Global
From €3840EUR$3,995USD£3,293GBP
- Report
- June 2022
- 257 Pages
Global
From €5046EUR$5,250USD£4,327GBP
- Report
- February 2018
- 103 Pages
Global
From €3364EUR$3,500USD£2,885GBP
- Report
- August 2018
- 29 Pages
Global
From €1056EUR$1,099USD£906GBP
- Report
- June 2019
- 130 Pages
United States
€2879EUR$2,995USD£2,469GBP
- Report
- August 2020
- 142 Pages
Global
From €4325EUR$4,500USD£3,709GBP
- Book
- October 2020
- 288 Pages
- Book
- July 2012
- 448 Pages
Brain cancer is a type of cancer that originates in the brain. It is a subset of oncology, the branch of medicine that deals with the diagnosis and treatment of cancer. Brain cancer can be caused by a variety of factors, including genetic mutations, environmental exposures, and lifestyle choices. Symptoms of brain cancer can include headaches, seizures, changes in vision, and changes in behavior. Treatment options for brain cancer include surgery, radiation therapy, chemotherapy, and targeted therapy.
Brain cancer is a serious and life-threatening condition, and the prognosis for patients with brain cancer varies depending on the type and stage of the cancer. Research into new treatments for brain cancer is ongoing, and new treatments are being developed to improve outcomes for patients.
Companies in the brain cancer market include Novocure, ImmunoCellular Therapeutics, and Celldex Therapeutics. Show Less Read more
